Related Experiment Videos
Improvement of progressive multifocal leukoencephalopathy after cidofovir therapy in a patient with a destructive
J F Viallard1, E Lazaro, E Ellie
1Service de Médecine Interne et Maladies Infectieuses, Hôpital Haut-Lévêque, 5, avenue de Magellan, Pessac Cedex, France. jean-francois.viallard@chu-bordeaux.fr
Abstract:
The human neurotropic JC virus (JCV) is responsible for progressive multifocal leukoencephalopathy (PML), an infectious demyelinating brain disease with major morbidity and mortality, usually refractory to treatment. We describe a PML in a 67-year-old woman with a destructive polyarthritis associated with anti-JO1 antibodies treated with corticosteroids. Although glucocorticoid therapy was maintained, administration of cidofovir improved the neurological condition. Our observation demonstrates the expanding clinical importance of JCV in systemic rheumatic diseases, particularly when immunosuppressive agents are used, and neurological symptoms or white matter changes on central nervous system imaging should arouse the suspicion of PML.
Insights
Progressive multifocal leukoencephalopathy (PML), a brain disease caused by JC virus (JCV), can occur in patients with autoimmune diseases. Treatment with cidofovir improved neurological symptoms in a patient with anti-JO1 antibody-associated polyarthritis.
Area of Science:
- Neurovirology
- Rheumatology
- Neurology
Background:
- JC virus (JCV) causes progressive multifocal leukoencephalopathy (PML), a severe demyelinating brain disease.
- PML is often refractory to treatment and associated with significant morbidity and mortality.
- Systemic rheumatic diseases, particularly those treated with immunosuppressants, may increase PML risk.
Observation:
- A 67-year-old woman with anti-JO1 antibody-associated polyarthritis and corticosteroid treatment developed PML.
- Neurological symptoms persisted despite ongoing glucocorticoid therapy.
- Central nervous system imaging revealed white matter changes suggestive of PML.
Findings:
- Administration of cidofovir led to neurological improvement in the patient.
- This case highlights the potential for JCV to manifest in the context of systemic rheumatic diseases.
- The use of immunosuppressive agents in rheumatic disease patients warrants vigilance for PML.
Implications:
- JC virus (JCV) should be considered in the differential diagnosis of neurological symptoms in patients with rheumatic diseases, especially those on immunosuppressants.
- Early detection and treatment of PML may improve patient outcomes.
- This case underscores the importance of considering neurotropic viral infections in immunocompromised patients with neurological deficits.
Related Concept Videos
Cytomegalovirus Disease
Cryptococcal Meningitis
Arboviral Encephalitis
Encephalitis ll: Pathophysiology
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Leishmaniasis